BrainSightAI

BrainSightAI develops an AI-based platform offering connectomics for functional brain mapping, combining artificial intelligence and neuroscience to enable precision in neurological and psychiatric investigation. Its flagship product, VoxelBox, uses AI-driven connectomics to generate personalized brain maps with applications in brain tumor surgery, stroke rehabilitation, chronic pain management, and psychiatric disorders. VoxelBox enables clinicians to perform connectomic analysis to generate network maps and tractography, helping surgeons minimize damage to areas responsible for critical functions like language, thought, and emotion, while also guiding rehabilitation efforts for cognitive recovery. The platform offers both Clinical and Research versions, supporting neurosurgeons, psychiatrists, and neurologists with technology-driven healthcare solutions. BrainSightAI is the only Indian health tech company using deep tech including AI and machine learning to address pressing problems in the mental health and neurology space. The company was awarded Top Innovator at the ET Startup Awards 2024 and is pursuing FDA certification to access US and allied markets, with expansion plans across Indian Tier I and Tier II cities. Founded in 2019 and headquartered in Bengaluru, India, BrainSightAI has raised approximately $6.7 million in funding from investors including IAN Alpha Fund, IvyCap Ventures, Silver Needle, RedStart Labs, Avaana Capital, Info Edge Ventures, Entrepreneur First, Pfizer, and She Capital.

Healthcare IT > Provider > Clinical Operations > Decision Support > Diagnosis > Differential Diagnosis > Image Based > Radiology > Neurology > Neurology - AI